Details
Stereochemistry | ACHIRAL |
Molecular Formula | C20H21FN2O |
Molecular Weight | 324.3919 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
FCCCCCN1C=C(C(=O)NC2=CC=CC=C2)C3=CC=CC=C13
InChI
InChIKey=FZYJALPWLNXEIP-UHFFFAOYSA-N
InChI=1S/C20H21FN2O/c21-13-7-2-8-14-23-15-18(17-11-5-6-12-19(17)23)20(24)22-16-9-3-1-4-10-16/h1,3-6,9-12,15H,2,7-8,13-14H2,(H,22,24)
Molecular Formula | C20H21FN2O |
Molecular Weight | 324.3919 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/23551277Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/25921407
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23551277
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/25921407
SDB-006 is a cannabimimetic indole that binds the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors with EC50 values of 19 and 134 nM, respectively. SDB-006 was discovered during research of the related compound JWH-018 adamantyl carboxamide, which has been sold illicitly in herbal blends.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL253 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23551277 |
6.88 null [pEC50] | ||
Target ID: CHEMBL218 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23551277 |
6.94 null [pEC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23551277
Mouse AtT20 neuroblastoma cells stably transfected with human CB1 or human CB2 were used for activity evaluation. Membrane potential was measured using a FLIPR Membrane Potential Assay kit (blue) from Molecular Devices. The dye was reconstituted with assay buffer of composition (mM): NaCl 145, HEPES 22, Na2HPO4 0.338, NaHCO3 4.17, KH2PO4 0.441, MgSO4 0.407, MgCl2 0.493, CaCl2 1.26, glucose 5.56 (pH 7.4, osmolarity 315 ± 5). Prior to the assay, cells were loaded with 90 μL/well of the dye solution without removal of the L-15, giving an initial assay volume of 180 μL/well. Plates were then incubated at 37 °C at ambient CO2 for 45 min. Fluorescence was measured using a FlexStation 3 (Molecular Devices) microplate reader with cells excited at a wavelength of 530 nm and emission measured at 565 nm. Baseline readings were taken every 2 s for at least 2 min, at which time either drug (SDB-006) or vehicle was added in a volume of 20 μL. The background fluorescence of cells without dye or dye without cells was negligible. Changes in fluorescence were expressed as a percentage of baseline fluorescence after subtraction of the changes produced by vehicle addition, which was less than 2% for drugs dissolved in assay buffer or DMSO. The final concentration of DMSO was not more than 0.1%.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:15:10 GMT 2023
by
admin
on
Sat Dec 16 09:15:10 GMT 2023
|
Record UNII |
3X4PHX3PGF
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-LTI-701
Created by
admin on Sat Dec 16 09:15:10 GMT 2023 , Edited by admin on Sat Dec 16 09:15:10 GMT 2023
|
||
|
WIKIPEDIA |
Designer-drugs-5F-SDB-005
Created by
admin on Sat Dec 16 09:15:10 GMT 2023 , Edited by admin on Sat Dec 16 09:15:10 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
91936840
Created by
admin on Sat Dec 16 09:15:10 GMT 2023 , Edited by admin on Sat Dec 16 09:15:10 GMT 2023
|
PRIMARY | |||
|
1776086-01-1
Created by
admin on Sat Dec 16 09:15:10 GMT 2023 , Edited by admin on Sat Dec 16 09:15:10 GMT 2023
|
PRIMARY | |||
|
3X4PHX3PGF
Created by
admin on Sat Dec 16 09:15:10 GMT 2023 , Edited by admin on Sat Dec 16 09:15:10 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
Mouse AtT-20 neuroblastoma cells stably transfected with human CB2
EC50
|
||
|
TARGET -> AGONIST |
Mouse AtT-20 neuroblastoma cells stably transfected with human CB1
EC50
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |